<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Disturbance of miRNA expression may play a key role in the initiation and progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> should be viewed as a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disease, but previous studies have only screened dysregulated miRNAs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> from a panel of 96, 145, 287 and 455 miRNAs, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>It is necessary to identify new aberrantly expressed miRNAs in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study tissue samples were derived from patients undergoing a surgical procedure to remove a portion of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The expression profile of 904 miRNAs was analyzed using a miRCURYâ„¢ <z:chebi fb="17" ids="48010">LNA</z:chebi> Array from 6-paired <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="5" pm="."><plain>The expression levels of 4 miRNAs were compared by real-time PCR between colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>, and also the expression levels of metastatic miRNAs in different stages of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> were analyzed </plain></SENT>
<SENT sid="6" pm="."><plain>We found that 67 miRNA precursors are upregulated in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (p&lt;0.05) and 21 of those have never been reported in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>); 39 miRNA precursors are downregulated (p&lt;0.05) and 24 novel dysregulated miRNAs were identified in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>miR-31, miR-126 and miR-143 are differentially expressed between <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Here, we report an miRNA profile of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>, and we identified differential expression patterns of miRNAs between rectal and <z:hpo ids='HP_0003003'>colon cancers</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>This novel information may suggest the potential roles of these miRNAs in the diagnosis of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
</text></document>